The cannabinoid receptor agonist WIN 55,212-2 reduces the initial cerebral damage after hypoxic-ischemic injury in fetal lambs

Brain Research

Volumn 1362, Issue , 2010, Pages 150-159

  Alonso Alconada, Daniel ^a   Alvarez, Francisco J ^b   Alvarez, Antonia ^a   Mielgo, Victoria E ^b   Goñi De Cerio, Felipe ^a   Rey Santano, Maria C ^b   Caballero, Amale ^a   Martinez Orgado, Jose ^c   Hilario, Enrique ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Apoptosis; Brain damage; Cannabinoid; Hypoxia ischemia

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; PROTEIN S 100;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ARTIFICIAL VENTILATION; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN DAMAGE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN PERFUSION; CONTROLLED STUDY; FETUS; FLOW CYTOMETRY; LAMB; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; UMBILICAL CORD;

ANIMALS; BENZOXAZINES; CALCIUM CHANNEL BLOCKERS; DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; FEMALE; FETUS; HYPOXIA-ISCHEMIA, BRAIN; MORPHOLINES; NAPHTHALENES; NEUROPROTECTIVE AGENTS; PREGNANCY; PREGNANCY COMPLICATIONS; SHEEP, DOMESTIC;

ANIMALIA; OVIS ARIES;

EID: 78149360225     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.09.050     Document Type: Article

References (61)

1. T. Aguado, J. Palazuelos, K. Monory, N. Stella, B. Cravatt, B. Lutz, G. Marsicano, Z. Kokaia, M. Guzmán, and I. Galve-Roperh The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells J. Neurosci. 26 2006 1551 1561
2. F.J. Alvarez, H. Lafuente, M.C. Rey-Santano, V.E. Mielgo, E. Gastiasoro, M. Rueda, R.G. Pertwee, A.I. Castillo, J. Romero, and J. Martinez-Orgado Neuroprotective effects of the nonpsychoactive cannabinoid in hypoxic-ischemic newborn piglets Pediatr. Res. 64 2008 653 658
3. J.C. Ashton, R.M. Rahman, S.M. Nair, B.A. Sutherland, M. Glass, and I. Appleton Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain Neurosci. Lett. 412 2007 114 117
4. W. Balduini, S. Carloni, E. Mazzoni, and M. Cimino New therapeutic strategies in perinatal stroke Curr. Drug Targets CNS Neurol. Disord. 3 2004 315 323
5. C. Bendotti, F. Guglielmetti, M. Tortarolo, R. Samanin, and W.D. Hirst Differential expression of S100beta and glial fibrillary acidic protein in the hippocampus after kainic acid-induced lesions and mossy fiber sprouting in adult rat Exp. Neurol. 161 2000 317 329
6. M. Blennow, K. Savman, P. Ilves, M. Thoresen, and L. Rosengren Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants Acta Paediatr. 90 2001 1171 1175
7. B.W. Böttiger, S. Möbes, R. Glätzer, H. Bauer, A. Gries, P. Bärtsch, J. Motsch, and E. Martin Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans Circulation 103 2001 2694 2698
8. J.W. Calvert, and J.H. Zhang Pathophysiology of an hypoxic-ischemic insult during the perinatal period Neurol. Res. 27 2005 246 260
9. C. Charriaut-Marlangue, and Y. Ben-Ari A cautionary note on the use of TUNEL stain to determine apoptosis NeuroReport 7 1995 61 62
10. F. Docagne, V. Muñetón, D. Clemente, C. Ali, F. Loría, F. Correa, M. Hernangómez, L. Mestre, D. Vivien, and C. Guaza Excitotoxicity in a chronic model of multiple sclerosis. Neuroprotective effect of cannabinoids through CB1 and CB2 receptor activation Mol. Cell. Neurosci. 34 2007 551 561
11. A.J. du Plessis, and J.J. Volpe Perinatal brain injury in the preterm and term newborn Curr. Opin. Neurol. 15 2002 151 157
12. L.F. Eng, R.S. Ghirnikar, and Y.L. Lee Glial fibrillary acidic protein. GFAP-thirty-one years 1969-2000 Neurochem. Res. 25 2000 1439 1451
13. A. Falkowski, R. Hammond, V. Han, and B. Richardson Apoptosis in the preterm and near term ovine fetal brain and the effect of intermittent umbilical cord occlusion Brain Res. Dev. Brain Res. 136 2002 165 173
14. D. Fernandez-Lopez, J. Martinez-Orgado, E. Nuñez, J. Romero, P. Lorenzo, M.A. Moro, and I. Lizasoain Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats Pediatr. Res. 60 2006 169 173
15. D. Fernandez-Lopez, M.R. Pazos, R.M. Tolon, M.A. Moro, J. Romero, I. Lizasoain, and J. Martinez-Orgado The cannabinoid agonist Win55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats Pediatr. Res. 62 2007 255 260
16. C.J. Fowler Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents. Non-psychoactive cannabinoids, 'entourage' compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid psychotropic effects Brain Res. Brain Res. Rev. 41 2003 26 43
17. P.L. Gabbott, and M.G. Stewart Distribution of neurons and glia in the visual cortex area 17 of the adult albino rat. A quantitative description Neuroscience 21 1987 833 845
18. Y. Gavrieli, Y. Sherman, and S. Ben Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation J. Cell Biol. 119 1992 493 501
19. D. Gazzolo, P. Vinesi, M. Bartocci, M.C. Geloso, W. Bonacci, G. Serra, K.G. Haglid, and F. Michetti Elevated S100 blood levels as an early indicator of intraventricular haemorrhage in preterm infants. Correlation with cerebral Doppler velocimetry J. Neurol. Sci. 170 1999 32 35
20. R.G. Giffard, and R.A. Swanson Ischemia-induced programmed cell death in astrocytes Glia 50 2005 299 306
21. S.A. Golech, R.M. McCarron, Y. Chen, J. Bembry, F. Lenz, R. Mechoulam, E. Shohami, and M. Spatz Human brain endothelium. Coexpression and function of vanilloid and endocannabinoid receptors Brain Res. Mol. Brain Res. 132 2004 87 92
22. J. Gomez del Pulgar, M.L. De Ceballos, M. Guzman, and G. Velasco Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway J. Biol. Chem. 277 2002 36527 36533
23. F. Goñi-de-Cerio, A. Alvarez, A. Caballero, V.E. Mielgo, F.J. Alvarez, M.C. Rey-Santano, E. Gastiasoro, A. Valls-i-Soler, J. Bilbao, and E. Hilario Early cell death in the brain of fetal preterm lambs after hypoxic-ischemic injury Brain Res. 1151 2007 161 171
24. F. Goñi-de-Cerio, A. Alvarez, F.J. Alvarez, M.C. Rey-Santano, D. Alonso-Alconada, V.E. Mielgo, E. Gastiasoro, and E. Hilario MgSO4 treatment preserves the ischemia-induced reduction in S-100 protein without modification of the expression of endothelial tight junction molecules Histol. Histopathol. 24 2009 1129 1138
25. R.I. Grundy, M. Rabuffetti, and M. Beltramo Cannabinoids and neuroprotection Mol. Neurobiol. 24 2001 29 51
26. S.E. Hamrick, and D.M. Ferriero The injury response in the term newborn brain. Can we neuroprotect? Curr. Opin. Neurol. 16 2003 147 154
27. E. Hilario, M.C. Rey, F. Goñi, F.J. Alvarez, A. Caballero, E. Gastiasoro, S. Gomez-Urquijo, A. Valls-i-Soler, and A. Alvarez Cerebral blood flow and morphological changes after hypoxic-ischemic injury in preterm lambs Acta Paediatr. 94 2005 903 911
28. E. Hilario, A. Alvarez, F.J. Alvarez, E. Gastiasoro, and A. Valls-i-Soler Cellular mechanisms in perinatal hypoxic-ischemic brain Injury Curr. Pediat. Rev. 2 2006 131 141
29. M. Horn, and W. Schlote Delayed neuronal death and delayed neuronal recovery in the human brain following global ischemia Acta Neuropathol. 85 1992 79 87
30. A.C. Howlett, C.S. Breivogel, S.R. Childers, S.A. Deadwyler, R.E. Hampson, and L.J. Porrino Cannabinoid physiology and pharmacology. 30 years of progress Neuropharmacology 47 2004 345 358
31. T. Ikeda, Y. Murata, E.J. Quilligan, B.H. Choi, J.T. Parer, S. Doi, and S.D. Park Physiologic and histologic changes in near-term fetal lambs exposed to asphyxia by partial umbilical cord occlusion Am. J. Obstet. Gynecol. 178 1998 24 32
32. T.W. Klein Cannabinoid-based drugs as anti-inflammatory therapeutics Nat. Rev. 5 2005 400 411
33. T.W. Klein, B. Lane, C.A. Newton, and H. Friedman The cannabinoid system and cytokine network Proc. Soc. Exp. Biol. Med. 225 2000 1 8
34. L. Levene, D. Evans, S. Mason, and J. Brown An international network for evaluating neuroprotective therapy after severe birth asphyxia Semin. Perinatol. 23 1999 226 233
35. A.C. Lukaszevicz, N. Sampaio, C. Guegan, A. Benchoua, C. Couriaud, E. Chevalier, B. Sola, P. Lacombe, and B. Onteniente High sensitivity of protoplasmic cortical astroglia to focal ischemia J. Cereb. Blood Flow Metab. 22 2002 289 298
36. J. Martinez-Orgado, B. Fernandez-Frutos, R. Gonzalez, E. Romero, L. Urigüen, J. Romero, and M.P. Viveros Neuroprotection by the cannabinoid agonist WIN-55212 in an in vivo newborn rat model of acute severe asphyxia Brain Res. Mol. Brain Res. 114 2003 132 139
37. J. Martinez-Orgado, D. Fernandez-Lopez, I. Lizasoain, and J. Romero The seek of neuroprotection. Introducing cannabinoids Recent Pat. CNS Drug Discov. 2 2007 131 139
38. R. Mechoulam, D. Panikashvili, and E. Shohami Cannabinoids and brain injury. Therapeutic implications Trends Mol. Med. 8 2002 58 61
39. T. Mishima, and H. Hirase In vivo intracellular recording suggests that gray matter astrocytes in mature cerebral cortex and hippocampus are electrophysiologically homogeneous J. Neurosci. 30 2010 3093 3100
40. T. Nagayama, A.D. Sinor, R.P. Simon, J. Chen, S.H. Graham, K. Jin, and D.A. Greenberg Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures J. Neurosci. 19 1999 2987 2995
41. N. Nagdyman, W. Kömen, H.K. Ko, C. Müller, and M. Obladen Biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia Pediatr. Res. 49 2001 502 506
42. N. Nagdyman, W. Kömen, H.-K. Ko, C. Müller, and M. Obladen Early biochemical indicator of hypoxic-ischemic encephalopathy after birth asphyxia Pediat. Res. 49 2001 502 506
43. F.J. Northington, D.M. Ferriero, E.M. Graham, R.J. Traystman, and L.J. Martin Early neurodegeneration after hypoxia-ischemia in neonatal rat is necrosis while delayed neuronal death is apoptosis Neurobiol. Dis. 8 2001 207 219
44. J. Ong, J.M. Plane, J.M. Parent, and F.S. Silverstein Hypoxic-ischemic injury stimulates subventricular zone proliferation and neurogenesis in the neonatal rat Pediatr. Res. 58 2005 600 606
45. P. Pacher, and G. Haskó Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning Br. J. Pharmacol. 153 2008 252 262
46. T.N.K. Raju Some animal models for the study of perinatal asphyxia Biol. Neonate 62 1992 202 214
47. A.D. Sinor, S.M. Irvin, and D.A. Greenberg Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats Neurosci. Lett. 278 2000 157 160
48. E. Spandau, G. Karkavelas, V. Oubasi, P. Avgovstides-Savvopoulou, T. Loizidis, and O. Guiba-Tziampiri Effect of ketaminbe on hypoxic-ischemic brain damage in newborn rats vol. 819 1999 1 7
49. J. Steiner, H.G. Bernstein, H. Bielau, A. Berndt, R. Brisch, C. Mawrin, G. Keilhoff, and B. Bogerts Evidence for a wide extra-astrocytic distribution of S100B in human brain BMC Neurosci. 8 2007 2
50. C.C. Stichel, C.M. Müller, and K. Zilles Distribution of glial fibrillary acidic protein and vimentin immunoreactivity during rat visual cortex development J. Neurocytol. 20 1991 97 108
51. S.M. Sullivan, S.T. Björkman, S.M. Miller, P.B. Colditz, and D.V. Pow Morphological changes in white matter astrocytes in response to hypoxia/ischemia in the neonatal pig Brain Res. 1319 2010 164 174
52. K. Takuma, A. Baba, and T. Matsuda Astrocyte apoptosis. Implications for neuroprotection Prog. Neurobiol. 72 2004 111 127
53. K. Thorngren-Jerneck, C. Alling, A. Herbst, I. Amer-Wahlin, and K. Marsal S100 protein in serum as a prognostic marker for cerebral injury in term newborn infants with hypoxic ischemic encephalopathy Pediatr. Res. 55 2004 406 412
54. S. Van Os, W. Ruitenbeek, J. Hopman, and M. van de Bor Excitatory amino acid release and electrocortical brain activity after hypoxemia in near-term lambs Brain Dev. 28 2006 380 388
55. J.L.H. Van Reempts The hypoxic brain. Histological and ultrastructural aspects Behav. Brain Res. 14 1984 99 108
56. R.C. Vannucci, J.R. Conor, D.T. Mauger, C. Palmer, M.B. Smith, J. Towfighi, and S.J. Vannucci Rat model of perinatal hypoxic-ischemic brain damage J. Neurosci. Res. 55 1999 158 163
57. J.J. Volpe Hypoxic-ischemic encelopathy clinical aspects J.J. Volpe, Neurology of the Newborn 2001 WB Saunders Co Philadelphia 331 394
58. Y. Waksman, J.M. Olson, S.J. Carlisle, and G.A. Cabral The central cannabinoid receptor CB1 mediates inhibition of nitric oxide production by rat microglial cells J. Pharmacol. Exp. Ther. 288 1999 1357 1366
59. J. Yager Animals models of hypoxic-ischemic brain damage in the newborn Semin. Pediatr. Neurol. 11 2004 31 46
60. Z. Yang, M.V. Covey, C.L. Bitel, L. Ni, G.M. Jonakait, and S.W. Levison Sustained neocortical neurogenesis after neonatal hypoxic/ischemic injury Ann. Neurol. 61 2007 199 208
61. M. Zhang, B.R. Martin, M.W. Adler, R.K. Razdan, J.I. Jallo, and R.F. Tuma Cannabinoid CB2 receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model J. Cereb. Blood Flow Metab. 27 2007 1387 1396